Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? - Test2 - elhamkhani - TriplyDB

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

http://www.wikidata.org/entity/Q34777954

about

The ketogenic diet as a treatment paradigm for diverse neurological disorders Adenosine kinase: exploitation for therapeutic gain.Mitochondrial disorders: challenges in diagnosis & treatment Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet Neuroactive peptides as putative mediators of antiepileptic ketogenic diets.Therapies in inborn errors of oxidative metabolism.Adenosine dysfunction and adenosine kinase in epileptogenesis.Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.Adenylosuccinate lyase deficiency.Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation.Homeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy.Adenosine kinase determines the degree of brain injury after ischemic stroke in mice.A ketogenic diet reduces long-term potentiation in the dentate gyrus of freely behaving rats.Purines and the Anti-Epileptic Actions of Ketogenic Diets.Purines and neuronal excitability: links to the ketogenic diet The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy.Adenosine dysfunction in epilepsy.Ketogenic diet sensitizes glucose control of hippocampal excitability.The ketogenic diet: metabolic influences on brain excitability and epilepsy.Adenosinergic signaling in epilepsy Ketogenic diets and thermal pain: dissociation of hypoalgesia, elevated ketones, and lowered glucose in rats Purinergic signaling and energy homeostasis in psychiatric disorders Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches.Triheptanoin--a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment?The biochemistry of ketogenesis and its role in weight management, neurological disease and oxidative stress.Adenosine receptors and epilepsy: current evidence and future potential.Glycolytic inhibition by 2-deoxy-d-glucose abolishes both neuronal and network bursts in an in vitro seizure model.Adenosine: a fundamental factor formed from Fatty feasts for fighting fits?Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors.Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism?A ketogenic diet did not prevent effects on the ectonucleotidases pathway promoted by lithium-pilocarpine-induced status epilepticus in rat hippocampus.Acute creatine administration improves mitochondrial membrane potential and protects against pentylenetetrazol-induced seizures.Neurologic presentation, diagnostics, and therapeutic insights in a severe case of adenylosuccinate lyase deficiency.Anxiolytic Effect of Exogenous Ketone Supplementation Is Abolished by Adenosine A1 Receptor Inhibition in Wistar Albino Glaxo/Rijswijk Rats.

P2860

Q21129287-3183FA24-2DA7-429B-85EB-4C34ED07DC05 Q26852056-7E3B37EB-C570-45A9-9EAF-253B258E949C Q27000484-3D10958C-06EF-4421-9969-882476125932 Q33521220-F926E21C-9B58-41C1-B5F5-ED56721811C4 Q33569276-7B42000E-74F3-419C-9370-36CA87008E9B Q34055267-4CB5F314-75BE-4778-9EC7-300050BE5CDD Q34073789-57792605-B997-4DC3-864E-A107CC99FC5B Q34101256-F478C8BF-44F2-471C-89CF-B4E02B9A0F32 Q34193811-084FBE95-510A-4B15-8A3F-F33480054B05 Q34433219-F520F549-C1BE-4723-8970-BFC1E7B4EA2D Q34997511-3D3B5AFE-5094-4A92-8D7F-8D86FFE62E2D Q35072901-83C88AB4-CD45-4D42-98F5-E4257C131EE5 Q35108543-F9DA2ED8-684F-433B-B657-8294AC2411D6 Q35160483-5BBD85DA-6741-4340-9379-DFC5009D9F29 Q35513799-502202EF-9A9A-4EDD-96DC-CCC269367DD0 Q35624347-0FA389E9-CE56-48DA-BF7F-E69344DEEA5F Q35852049-9A6DE5B3-37F3-41B5-9FFF-DB61F7593906 Q36036212-69072263-F1E2-4668-B3B9-8184684EE22D Q36196783-5126CBA9-347D-470F-8ED0-CE3F44A2A402 Q36501202-7F138BAD-8189-4BD6-B8CE-5D16C3B30DE8 Q36643060-0CC49E67-8F86-4DE1-B809-5031B109B6DD Q36816412-28BB52E9-DFCA-4F62-9DF0-28C64F4741B0 Q37284060-B37AAC8D-84CA-4974-98BA-23828B654DA3 Q37426965-F4959C0E-B006-442E-9B95-73391AF83B7A Q37653680-3D2B63BB-CF02-4709-B37E-F049E6EF4519 Q37920144-5C756FC1-0531-4C5E-A4B0-B6D3B7BA7E57 Q37943703-4E924362-05F5-48C9-962F-33EA6EBBA18B Q38245140-D4DF388E-AB5C-4987-80B7-C11BF2142382 Q38839414-E4263D99-34EB-49AB-8540-3E480E2F56BA Q41160059-ABFB7A15-CD28-434A-9FDD-13E8E6A89B42 Q42177440-6BB35114-71A1-4F14-95B2-20E715E99396 Q45824470-8B476BF6-1C20-4627-AC97-ED0A4581DFF4 Q47192846-BD3719CE-1528-4838-B0F8-355DFCC05E87 Q48336710-DF5724A6-4ABC-45B1-9568-EBA347F5A1A6 Q50261731-A871132D-D30E-4451-9EB2-1C15014CDDC1 Q53838781-E5C671F0-4618-4A92-9AB1-05B995333D60

P2860

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

http://www.wikidata.org/entity/Q34777954

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

@ast

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

@en

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

@nl

type

label

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

@ast

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

@en

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

@nl

prefLabel

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

@ast

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

@en

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

@nl

P1433

Q34777954-B83D4F7A-E874-4CC9-86A5-6C68B7DCE7B5

P1476

Q34777954-9E14F58C-099B-4F79-937C-3797B63921F4

P2093

Q34777954-6F95443B-A385-4373-ADD5-84E7290C34D8

Q34777954-8F9D30DA-6677-4C2E-8A9A-BE879D7CFFB1

P2860

Q34777954-0B431835-07D2-4D2A-A744-84C6E5FF54C3

Q34777954-0BF05773-77E2-468A-9F14-207A3EAA1932

Q34777954-0CD98EA0-0D03-475D-8203-6AD0F9889FAF

Q34777954-0CFFE28E-6419-4877-8907-E5A613FBC28D

Q34777954-10D91A05-13B3-4801-B37D-0B6605582142

Q34777954-14270584-F263-49E1-AB9A-F9879EE3BA29

Q34777954-1F5C9691-6244-4E7D-932D-156B7FE25ECC

Q34777954-2334B2A0-299F-40A1-BE2C-6A8BD7288670

Q34777954-2519B1CE-B652-430B-95A8-2E8643C2B6CB

Q34777954-258309DF-9594-44CC-ADFE-9CEA422327C6

P304

Q34777954-D3C56279-B796-4574-BD9D-3F86D576EB1F

P31

Q34777954-32E474FF-C868-42E8-A8F1-7A40A4AE7789

P356

Q34777954-28E2B99B-9360-4BC4-9779-C747C6BA76B8

P433

Q34777954-089F4492-8EC5-4C40-AA16-A0486CB5CC07

P478

Q34777954-5DD511FA-BB22-49DB-8C7A-D8A7722D0C3B

P577

Q34777954-976D2E37-7223-4ED8-A923-BC924DF758AD

P5875

Q34777954-814CBCCC-794E-4A0D-9CEE-2E6CF77F0C3F

P698

Q34777954-5F762023-2448-4743-A366-FE69A90DD033

P932

Q34777954-D5A76DE6-0D98-4AAA-AB6B-70D24CFF3F5B

P356

J.TINS.2008.02.009

P1433

Trends in Neurosciences

P1476

Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

@en

P2093

Jonathan D Geiger

http://www.w3.org/2001/XMLSchema#string

Susan A Masino

http://www.w3.org/2001/XMLSchema#string

P2860

The Ketogenic Diet: One Decade Later

Adenosine receptors as therapeutic targets

Neuroprotective and disease-modifying effects of the ketogenic diet

The neuropharmacology of the ketogenic diet

Molecular targets for antiepileptic drug development

2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure

Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels

Adenosine receptor antagonists induce persistent bursting in the rat hippocampal CA3 region via an NMDA receptor-dependent mechanism

Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis

ATP modulation of excitatory synapses onto interneurons

P304

273-278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TINS.2008.02.009

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5379489

http://www.w3.org/2001/XMLSchema#string

P698

18471903

http://www.w3.org/2001/XMLSchema#string

P932

4469341

http://www.w3.org/2001/XMLSchema#string